{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:29:26Z","timestamp":1793046566273,"version":"4.5.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Vasodilatory shock, such as septic shock, requires personalized management which include adequate fluid therapy and vasopressor treatments. While these potent drugs are numerous, they all aim to counterbalance the vasodilatory effects of a systemic inflammatory response syndrome. Their specific receptors include \u03b1- and \u03b2-adrenergic receptors, arginine-vasopressin receptors, angiotensin II receptors and dopamine receptors. Consequently, these may be associated with severe adverse effects, including acute mesenteric ischemia (AMI). As the risk of AMI depends on drug class, we aimed to review the evidence of plausible associations by performing a worldwide pharmacovigilance analysis based on the World Health Organization database, VigiBase\u00ae. Among 24 million reports, 104 AMI events were reported, and disproportionality analyses yielded significant association with all vasopressors, to the exception of selepressin. Furthermore, in a comprehensive literature review, we detailed mechanistic phenomena which may enhance vasopressor selection, in the course of treating vasodilatory shock.<\/jats:p>","DOI":"10.3389\/fmed.2022.826446","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T01:02:05Z","timestamp":1653267725000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Mathieu","family":"Jozwiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Geri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Driss","family":"Laghlam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Boussion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dolladille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00134-015-3690-8","article-title":"Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases","volume":"41","author":"Leone","year":"2015","journal-title":"Intensive Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13017-015-0041-6","article-title":"The importance of open emergency surgery in the treatment of acute mesenteric ischemia","volume":"10","author":"Duran","year":"2015","journal-title":"World J Emerg Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.3748\/wjg.v27.i26.4088","article-title":"Non-occlusive mesenteric ischemia: Diagnostic challenges and perspectives in the era of artificial intelligence","volume":"27","author":"Bourcier","year":"2021","journal-title":"World J Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2165\/00002018-200427120-00003","article-title":"Data quality management in pharmacovigilance","volume":"27","author":"Lindquist","year":"2004","journal-title":"Drug safety."},{"key":"B6","volume-title":"Introductory Guide to MedDRA.","year":"2022"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0962280211403604","article-title":"Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery","volume":"22","author":"Nor\u00e9n","year":"2013","journal-title":"Stat Methods Med Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMc1901677","article-title":"Abatacept for severe immune checkpoint inhibitor-associated myocarditis","volume":"380","author":"Salem","year":"2019","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.jacc.2019.07.056","article-title":"Cardiovascular toxicities associated with ibrutinib","volume":"74","author":"Salem","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.119.040162","article-title":"Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes","volume":"140","author":"Salem","year":"2019","journal-title":"Circulation."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab362","article-title":"Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study","author":"Salem","year":"2021","journal-title":"Eur Heart J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.120.048238","article-title":"Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the world health organization pharmacovigilance database","volume":"142","author":"Nguyen","year":"2020","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40264-016-0405-1","article-title":"Good signal detection practices: evidence from IMI PROTECT","volume":"39","author":"Wisniewski","year":"2016","journal-title":"Drug safety."},{"key":"B17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/SHK.0000000000001022","article-title":"Vasopressor cumulative dose requirement and risk of early death during septic shock: an analysis from the EPISS cohort","volume":"49","author":"Dargent","year":"2018","journal-title":"Shock."},{"key":"B18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0885066612448738","article-title":"Outcomes of patients on multiple vasoactive drugs for shock","volume":"28","author":"Prys-Picard","year":"2013","journal-title":"J Intensive Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1001\/jama.2020.19400","article-title":"Gastrointestinal complications in critically ill patients with and without COVID-19","volume":"324","author":"El Moheb","year":"2020","journal-title":"Jama."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1097\/01.CCM.0000215834.48023.57","article-title":"Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis","volume":"34","author":"Krejci","year":"2006","journal-title":"Crit Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/00003246-199810000-00034","article-title":"Effects of vasoactive drugs on gastric intramucosal pH","volume":"26","author":"Silva","year":"1998","journal-title":"Crit Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00134-006-0175-9","article-title":"Influence of severity of illness, medication and selective decontamination on defecation","volume":"32","author":"van der Spoel","year":"2006","journal-title":"Intensive Care Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/SHK.0000000000000720","article-title":"Acute mesenteric ischemia among postcardiac surgery patients presenting with multiple organ failure","volume":"47","author":"Guillaume","year":"2017"},{"key":"B24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.12688\/f1000research.52782.1","article-title":"Vasoactive agents in acute mesenteric ischaemia in critical care. A systematic review","volume":"10","author":"Brennan","year":"2021","journal-title":"F1000Res."},{"key":"B25","first-page":"415","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"De Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/cells10071767","article-title":"Renin-angiotensin-aldosterone system and immunomodulation: a state-of-the-art review","volume":"10","author":"Laghlam","year":"2021","journal-title":"Cells."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/hy1201.101214","article-title":"History about the discovery of the renin-angiotensin system","volume":"38","author":"Basso","year":"2001","journal-title":"Hypertension."},{"key":"B28","doi-asserted-by":"publisher","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin II in experimental hyperdynamic sepsis","volume":"13","author":"Wan","year":"2009","journal-title":"Crit Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00134-012-2487-2","article-title":"Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion","volume":"38","author":"May","year":"2012","journal-title":"Intensive Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1097\/CCM.0000000000000397","article-title":"Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis","volume":"42","author":"Corr\u00eaa","year":"2014","journal-title":"Crit Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/S0140-6736(95)91933-3","article-title":"Severe septic shock unresponsive to noradrenaline","volume":"346","author":"Wray","year":"1995","journal-title":"Lancet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jama.1961.03040490020005","article-title":"Clinical experience with angiotensin II in the treatment of shock","volume":"178","author":"Del Greco","year":"1961","journal-title":"JAMA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/01.CIR.25.1.263","article-title":"Adjunctive use of a biologic pressor agent, angiotensin, in management of shock","volume":"25","author":"Derrick","year":"1962","journal-title":"Circulation."},{"key":"B34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/SHK.0000000000000807","article-title":"Angiotensin II in refractory septic shock","volume":"47","author":"Antonucci","year":"2017","journal-title":"Shock."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/00003246-199108000-00020","article-title":"Administration of angiotensin II in refractory septic shock","volume":"19","author":"Thomas","year":"1991","journal-title":"Crit Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care."},{"key":"B37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/MCC.0000000000000517","article-title":"Vasodilatory shock in the ICU and the role of angiotensin II","volume":"24","author":"Wakefield","year":"2018","journal-title":"Curr Opin Crit Care."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin ii for catecholamine-resistant vasodilatory shock: a clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.0001-5172.2004.00283.x","article-title":"The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model","volume":"48","author":"Laesser","year":"2004","journal-title":"Acta Anaesthesiol Scand."},{"key":"B42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/SHK.0b013e31815dd780","article-title":"Low-dose candesartan improves renal blood flow and kidney oxygen tension in rats with endotoxin-induced acute kidney dysfunction","volume":"30","author":"Nitescu","year":"2008","journal-title":"Shock."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/CCM.0000000000002441","article-title":"Clinical experience with IV angiotensin II administration: a systematic review of safety","volume":"45","author":"Busse","year":"2017","journal-title":"Crit Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-020-0628-2","article-title":"Vasopressin and its analogues in shock states: a review","volume":"10","author":"Demiselle","year":"2020","journal-title":"Ann Intensive Care."},{"key":"B45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","article-title":"Vasopressin: mechanisms of action on the vasculature in health and in septic shock","volume":"35","author":"Barrett","year":"2007","journal-title":"Crit Care Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1124\/jpet.111.178848","article-title":"Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension","volume":"337","author":"Laporte","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00005344-198007000-00004","article-title":"Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension","volume":"2","author":"M\u00f6hring","year":"1980","journal-title":"J Cardiovasc Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0002-8703(41)90649-X","article-title":"Circulatory effects following the intravenous administration of pitressin in normal persons and in patients with hypertension and angina pectoris","volume":"21","author":"Graybiel","year":"1941","journal-title":"Am Heart J."},{"key":"B49","first-page":"869","article-title":"Vasopressin release during sepsis and septic shock in baboons and dogs","volume":"153","author":"Wilson","year":"1981","journal-title":"Surg Gynecol Obstet."},{"key":"B50","first-page":"273","article-title":"Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia","volume":"17","author":"Brackett","year":"1985","journal-title":"Circ Shock."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation."},{"key":"B52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","article-title":"Depletion of neurohypophyseal content of vasopressin in septic shock","volume":"30","author":"Sharshar","year":"2002","journal-title":"Crit Care Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","article-title":"Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach","volume":"160","author":"Annane","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF01819137","article-title":"Spectral analysis of heart rate variability in the sepsis syndrome","volume":"3","author":"Garrard","year":"1993","journal-title":"Clin Auton Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1097\/CCM.0b013e3181eb9acf","article-title":"Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock","volume":"38","author":"Siami","year":"2010","journal-title":"Crit Care Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(03)14899-4","article-title":"Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock","volume":"362","author":"Sharshar","year":"2003","journal-title":"Lancet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1750-3639.2009.00355.x","article-title":"Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock","volume":"20","author":"Sonneville","year":"2010","journal-title":"Brain Pathol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"H663","DOI":"10.1152\/ajpheart.1982.243.5.H663","article-title":"Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs","volume":"243","author":"Liard","year":"1982","journal-title":"Am J Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jss.2018.10.028","article-title":"Dobutamine versus vasopressin after mesenteric ischemia","volume":"235","author":"Bomberg","year":"2019","journal-title":"J Surg Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1124\/jpet.116.234930","article-title":"Vasopressin is involved in endothelin receptor antagonist-induced fluid retention in rat. Differential effect of selective ETA and dual ETA\/ETB receptor antagonists","volume":"40","author":"Vercauteren","year":"2012","journal-title":"Eur Resp J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-019-2362-4","article-title":"The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis","volume":"23","author":"Jiang","year":"2019","journal-title":"Crit Care."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0431","DOI":"10.1097\/MD.0000000000010431","article-title":"Terlipressin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)."},{"key":"B65","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bpa.2008.02.002","article-title":"Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage","volume":"22","author":"D\u00f6hler","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Liu","year":"2018","journal-title":"Intensive Care Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3389\/fphar.2019.01492","article-title":"Terlipressin versus norepinephrine for septic shock: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fphar.2020.00563","article-title":"Clinical efficiency of vasopressin or its analogs in comparison with catecholamines alone on patients with septic shock: a systematic review and meta-analysis","volume":"11","author":"Yao","year":"2020","journal-title":"Front Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","article-title":"A selective V(1A) receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock","volume":"44","author":"He","year":"2016","journal-title":"Crit Care Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1097\/CCM.0000000000000300","article-title":"The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*","volume":"42","author":"Maybauer","year":"2014","journal-title":"Crit Care Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"H1245","DOI":"10.1152\/ajpheart.00390.2012","article-title":"Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis","volume":"303","author":"Rehberg","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/CCM.0b013e3181fa3898","article-title":"Role of selective V1a receptor agonism in ovine septic shock","volume":"39","author":"Rehberg","year":"2011","journal-title":"Crit Care Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1124\/jpet.120.000146","article-title":"Protective mechanism of the selective vasopressin V(1A) receptor agonist selepressin against endothelial barrier dysfunction","volume":"375","author":"Barabutis","year":"2020","journal-title":"J Pharmacol Exp Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V(1A) agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit Care."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"R142","DOI":"10.1186\/cc9207","article-title":"Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension","volume":"14","author":"Hamzaoui","year":"2010","journal-title":"Crit Care."},{"key":"B77","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/CCM.0b013e318206d2a3","article-title":"Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients","volume":"39","author":"Monnet","year":"2011","journal-title":"Crit Care Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","article-title":"Effects of norepinephrine on mean systemic pressure and venous return in human septic shock","volume":"40","author":"Persichini","year":"2012","journal-title":"Crit Care Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13054-021-03711-5","article-title":"Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock","volume":"25","author":"Adda","year":"2021","journal-title":"Crit Care."},{"key":"B80","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bja.2017.11.065","article-title":"Norepinephrine exerts an inotropic effect during the early phase of human septic shock","volume":"120","author":"Hamzaoui","year":"2018","journal-title":"Br J Anaesth."},{"key":"B81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0040-1710320","article-title":"Vasopressor therapy in the intensive care unit","volume":"42","author":"Russell","year":"2021","journal-title":"Semin Respir Crit Care Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1164\/rccm.200109-016OC","article-title":"Microvascular blood flow is altered in patients with sepsis","volume":"166","author":"Backer","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s00134-010-2013-3","article-title":"Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients","volume":"36","author":"Georger","year":"2010","journal-title":"Intensive Care Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"104068","DOI":"10.1016\/j.mvr.2020.104068","article-title":"Assessment of tissue oxygenation to personalize mean arterial pressure target in patients with septic shock","volume":"132","author":"Jozwiak","year":"2020","journal-title":"Microvasc Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","article-title":"Potentially inadvertent immunomodulation: norepinephrine use in sepsis","volume":"194","author":"Stolk","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit Care."},{"key":"B87","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13613-015-0052-1","article-title":"Experts' recommendations for the management of adult patients with cardiogenic shock","volume":"5","author":"Levy","year":"2015","journal-title":"Ann Intensive Care."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/aas.12780","article-title":"Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure","volume":"60","author":"M\u00f8ller","year":"2016","journal-title":"Acta Anaesthesiol Scand."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2012","journal-title":"Eur Heart J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s00134-017-4909-7","article-title":"Intensive care medicine in 2050: vasopressors in sepsis","volume":"44","author":"Teboul","year":"2018","journal-title":"Intensive Care Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/SHK.0000000000001726","article-title":"A randomized porcine study in low cardiac output of vasoactive and inotropic drug effects on the gastrointestinal tract","volume":"56","author":"Seilitz","year":"2021","journal-title":"Shock."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","article-title":"Vasopressor therapy in critically ill patients with shock","volume":"45","author":"Russell","year":"2019","journal-title":"Intensive Care Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet."},{"key":"B96","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s001340050329","article-title":"Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study","volume":"23","author":"Levy","year":"1997","journal-title":"Intensive Care Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00134-002-1611-0","article-title":"Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/SHK.0b013e318167378f","article-title":"Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states","volume":"30","author":"Levy","year":"2008","journal-title":"Shock."},{"key":"B99","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0140-6736(05)71045-X","article-title":"Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study","volume":"365","author":"Levy","year":"2005","journal-title":"Lancet."},{"key":"B100","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/00003246-199905000-00021","article-title":"Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock","volume":"27","author":"Duranteau","year":"1999","journal-title":"Crit Care Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1097\/01.CCM.0000063045.77339.B6","article-title":"Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?","volume":"31","author":"de Backer","year":"2003","journal-title":"Crit Care Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/00003246-199710000-00013","article-title":"Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock","volume":"25","author":"Levy","year":"1997","journal-title":"Crit Care Med."},{"key":"B104","first-page":"654","article-title":"Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock","volume":"23","author":"Zhou","year":"2002","journal-title":"Acta Pharmacol Sin."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1097\/00003246-200008000-00034","article-title":"Low potential of dobutamine and dopexamine to block intestinal peristalsis as compared with other catecholamines","volume":"28","author":"Fruhwald","year":"2000","journal-title":"Crit Care Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/MCC.0000000000000743","article-title":"Vasopressor use in cardiogenic shock","volume":"26","author":"Levy","year":"2020","journal-title":"Curr Opin Crit Care."},{"key":"B107","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study","volume":"39","author":"Levy","year":"2011","journal-title":"Crit Care Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s10877-018-0177-5","article-title":"Boosting systemic pressure with phenylephrine: arterial or venous modulation?","volume":"32","author":"Jozwiak","year":"2018","journal-title":"J Clin Monit Comput."},{"key":"B110","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/EJA.0000000000000470","article-title":"Preload dependency determines the effects of phenylephrine on cardiac output in anaesthetised patients: a prospective observational study","volume":"33","author":"Rebet","year":"2016","journal-title":"Eur J Anaesthesiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/00000542-199101000-00026","article-title":"Ejection fraction revisited","volume":"74","author":"Robotham","year":"1991","journal-title":"Anesthesiology."},{"key":"B112","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10877-018-0126-3","article-title":"Phenylephrine increases cardiac output by raising cardiac preload in patients with anesthesia induced hypotension","volume":"32","author":"Kalmar","year":"2018","journal-title":"J Clin Monit Comput."},{"key":"B113","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1213\/00000539-199308000-00004","article-title":"The effect of phenylephrine bolus administration on left ventricular function during isoflurane-induced hypotension","volume":"77","author":"Goertz","year":"1993","journal-title":"Anesth Analg."},{"key":"B114","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/01.CCM.0000201879.20281.C6","article-title":"Vasopressors and intestinal mucosal perfusion after cardiac surgery: norepinephrine vs. phenylephrine","volume":"34","author":"Nygren","year":"2006","journal-title":"Crit Care Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2147\/TCRM.S80060","article-title":"Vasopressors in septic shock: a systematic review and network meta-analysis","volume":"11","author":"Zhou","year":"2015","journal-title":"Ther Clin Risk Manag."},{"key":"B116","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/cc7121","article-title":"Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial","volume":"12","author":"Morelli","year":"2008","journal-title":"Crit Care."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2017.2841","article-title":"Association between US norepinephrine shortage and mortality among patients with septic shock","volume":"317","author":"Vail","year":"2017","journal-title":"JAMA."},{"key":"B118","first-page":"271","article-title":"Peripheral vascular and other effects of dopamine infusions in man","volume":"27","author":"Allwood","year":"1964","journal-title":"Clin Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3109\/13813458409071158","article-title":"The use of low doses of dopamine in intensive care medicine Arch Int Physiol Biochim","volume":"92","author":"D'Orio","year":"1984"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1097\/00003246-199609000-00024","article-title":"Anterior pituitary function during critical illness and dopamine treatment","volume":"24","author":"Van den Berghe","year":"1996","journal-title":"Crit Care Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11481-019-09851-4","article-title":"Where is dopamine and how do immune cells see it?: Dopamine-mediated immune cell function in health and disease.","volume":"15","author":"Matt","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s001340051279","article-title":"Effect of dopamine on gastrointestinal motility during critical illness","volume":"26","author":"Dive","year":"2000","journal-title":"Intensive Care Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"Backer","year":"2010","journal-title":"New Engl J Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/SHK.0b013e3181c6ba6f","article-title":"Efficacy and safety of dopamine versus norepinephrine in the management of septic shock","volume":"33","author":"Patel","year":"2010","journal-title":"Shock."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.826446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T01:02:11Z","timestamp":1653267731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.826446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":124,"alternative-id":["10.3389\/fmed.2022.826446"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.826446","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"article-number":"826446"}}